Omalizumab in middle-aged or older patients with severe allergic asthma-COPD overlap

Introduction: Biological therapies used for severe asthma may be useful even for middle-aged or older patients who have a history of severe allergic asthma with a chronic obstructive pulmonary disease (COPD) overlap phenotype.